$ITOR
Intorio, Corp.

2022 Q3 Form 10-Q Financial Statement

#000168316822006727 Filed on October 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.940K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.330K
YoY Change
% of Gross Profit
Operating Expenses $5.943K $10.42K
YoY Change 34.88%
Operating Profit -$5.943K -$10.42K
YoY Change 34.88%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.943K
YoY Change 34.88%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.943K -$10.42K
YoY Change 34.88% 57.89%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 3.235M shares 3.235M shares
Diluted Shares Outstanding 3.235M shares 3.235M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.960K
YoY Change
Cash & Equivalents $3.959K $7.596K $15.85K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.959K $15.85K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.999K $6.333K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.959K $15.85K
Total Long-Term Assets $4.999K $6.333K
Total Assets $8.958K $22.18K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.50K $15.50K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $6.380K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.88K $21.74K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $24.88K $21.74K
Total Long-Term Liabilities $0.00
Total Liabilities $24.88K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$40.82K -$24.46K
YoY Change
Common Stock $323.00 $323.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.92K -$9.978K $441.00
YoY Change
Total Liabilities & Shareholders Equity $8.958K $22.18K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$5.943K -$10.42K
YoY Change 34.88% 57.89%
Depreciation, Depletion And Amortization $1.330K
YoY Change
Cash From Operating Activities -$12.03K -$8.252K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $200.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 140.0 $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -12.03K -$8.252K
Cash From Investing Activities
Cash From Financing Activities 140.0 $0.00
Net Change In Cash -11.89K -$8.252K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$12.03K -$8.252K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001852536
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-255055
dei Entity Registrant Name
EntityRegistrantName
Intorio, Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1578603
dei Entity Address Address Line1
EntityAddressAddressLine1
24 Alexander Kazbegi Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
Tblisi
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
0177
dei Entity Address Country
EntityAddressCountry
GE
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
605-4636
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3235000 shares
CY2022Q3 us-gaap Cash
Cash
3959 usd
CY2022Q1 us-gaap Cash
Cash
15848 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
3959 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
15848 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4001 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2667 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
4999 usd
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
6333 usd
CY2022Q3 us-gaap Assets
Assets
8958 usd
CY2022Q1 us-gaap Assets
Assets
22181 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
18500 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15500 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
6379 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
6240 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
24879 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
21740 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3235000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3235000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
323 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
323 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24577 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24577 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40821 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24459 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15921 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8958 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22181 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5943 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4406 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16362 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11005 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
5943 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
4406 usd
us-gaap Operating Expenses
OperatingExpenses
16362 usd
us-gaap Operating Expenses
OperatingExpenses
11005 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5943 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4406 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-16362 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11005 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5943 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4406 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16362 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11005 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5943 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4406 usd
us-gaap Net Income Loss
NetIncomeLoss
-16362 usd
us-gaap Net Income Loss
NetIncomeLoss
-11005 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2946033 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2354313 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3235000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2946033 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3235000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2354313 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1753 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1553 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6599 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-8152 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
24700 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4406 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
12142 usd
us-gaap Net Income Loss
NetIncomeLoss
-22706 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10419 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-9978 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5943 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15921 usd
us-gaap Net Income Loss
NetIncomeLoss
-16362 usd
us-gaap Net Income Loss
NetIncomeLoss
-11005 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1334 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12028 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6505 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24700 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
139 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4349 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29049 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11889 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
22544 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15848 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3959 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22544 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40821 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24459 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zPJ42JNtMWye" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_863_z4ED8SIJg6P2">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the limited level of operations during the reporting period, the Company made no material assumptions or estimates other than the assumption that the Company is a going concern and estimate with reference to amortization of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2022Q3 us-gaap Cash
Cash
3959 usd
CY2022Q1 us-gaap Cash
Cash
15848 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
6379 usd
CY2022Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
6240 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
1500 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares

Files In Submission

Name View Source Status
0001683168-22-006727-index-headers.html Edgar Link pending
0001683168-22-006727-index.html Edgar Link pending
0001683168-22-006727.txt Edgar Link pending
0001683168-22-006727-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
intorio_10q-083122.htm Edgar Link pending
intorio_ex3101.htm Edgar Link pending
intorio_ex3102.htm Edgar Link pending
intorio_ex3201.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20220831.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20220831_cal.xml Edgar Link unprocessable
none-20220831_def.xml Edgar Link unprocessable
none-20220831_lab.xml Edgar Link unprocessable
none-20220831_pre.xml Edgar Link unprocessable
intorio_10q-083122_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending